indigenous
发表于 2025-3-30 11:56:40
http://reply.papertrans.cn/19/1813/181210/181210_51.png
不能强迫我
发表于 2025-3-30 12:33:47
http://reply.papertrans.cn/19/1813/181210/181210_52.png
GRE
发表于 2025-3-30 18:13:15
Book 1989 lung cancer every minute globally. The first chapter is from the Cancer Unit, WHO, Geneva, and describes in detail the epidemiologic features of lung cancer, which is the second most frequent cancer in the world with 660,500 new cases annually; it will soon surpass stomach cancer as the leader. Thi
biopsy
发表于 2025-3-30 21:36:06
Autocrine Growth Factors and Lung Cancer,an be administered to patients, as is the case with monoclonal antibody , make this area especially promising. In this chapter we will review the development of growth factor research, attempting to summarize the current state of understanding of the role of growth factors especially as they rela
出生
发表于 2025-3-31 02:51:48
CNS Therapy in Small-Cell Lung Cancer,they did become more frequent with increasing survival time . Accordingly, those with most benefit from current treatment of SCLC are running the highest risk of developing this complication. Some of the fundamental problems in establishing the true dimension of the problem have been described
笨重
发表于 2025-3-31 08:22:58
http://reply.papertrans.cn/19/1813/181210/181210_56.png
虚情假意
发表于 2025-3-31 09:19:24
Book 1989nical Aspects. The present book continues the outline of the previous volume by presenting up-to-date information on lung cancer in critical reviews of new important basic and clinical concepts of lung cancer. The present volume has broadened the scope by also including chapters dealing with issues
青少年
发表于 2025-3-31 15:10:11
Oncogenes and Human Lung Cancer,with significant activity in lung cancer are difficult to find, and the results of early clinical trials with biological agents such as the interferons or interleukins raise little hope of major activity.
滑稽
发表于 2025-3-31 20:38:47
http://reply.papertrans.cn/19/1813/181210/181210_59.png
控制
发表于 2025-3-31 23:42:32
Late Complications Associated with the Treatment of Small-Cell Lung Cancer,apidly, and is usually very widely disseminated at the time of diagnosis . In contradistinction to non-small-cell lung tumors, SCLC is very responsive to single-agent chemotherapy as well as combinations, even in patients with advanced disease.